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Osteoarthritis (OA) is the most common musculoskeletal disorder. Although joint
replacement remains the standard of care for knee OA patients, knee joint distraction
(KJD), which works by temporarily off-loading the joint for 6–8 weeks, is becoming
a novel joint-sparing alternative for younger OA sufferers. The biological mechanisms
behind KJD structural improvements remain poorly understood but likely involve joint-
resident regenerative cells including multipotent stromal cells (MSCs). In this study,
we hypothesized that KJD leads to beneficial cartilage-anabolic and anti-catabolic
changes in joint-resident MSCs and investigated gene expression profiles of synovial
fluid (SF) MSCs following KJD as compared with baseline. To obtain further insights
into the effects of local biomechanics on MSCs present in late OA joints, SF MSC
gene expression was studied in a separate OA arthroplasty cohort and compared with
subchondral bone (SB) MSCs from medial (more loaded) and lateral (less loaded) femoral
condyles from the same joints. In OA arthroplasty cohort (n = 12 patients), SF MSCs
expressed lower levels of ossification- and hypotrophy-related genes [bone sialoprotein
(IBSP), parathyroid hormone 1 receptor (PTH1R), and runt-related transcription factor
2 (RUNX2)] than did SB MSCs. Interestingly, SF MSCs expressed 5- to 50-fold
higher levels of transcripts for classical extracellular matrix turnover molecules matrix
metalloproteinase 1 (MMP1), a disintegrin and metalloproteinase with thrombospondin
motifs 5 (ADAMTS5), and tissue inhibitor of metalloproteinase-3 (TIMP3), all (p < 0.05)
potentially indicating greater cartilage remodeling ability of OA SF MSCs, compared
with SB MSCs. In KJD cohort (n = 9 patients), joint off-loading resulted in sustained,
significant increase in SF MSC colonies’ sizes and densities and a notable transcript
upregulation of key cartilage core protein aggrecan (ACAN) (weeks 3 and 6), as well
as reduction in pro-inflammatory C–C motif chemokine ligand 2 (CCL2) expression
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(weeks 3 and 6). Additionally, early KJD changes (week 3) were marked by significant
increases in MSC chondrogenic commitment markers gremlin 1 (GREM1) and growth
differentiation factor 5 (GDF5). In combination, our results reveal distinct transcriptomes
on joint-resident MSCs from different biomechanical environments and show that 6-
week joint off-loading leads to transcriptional changes in SF MSCs that may be beneficial
for cartilage regeneration. Biomechanical factors should be certainly considered in the
development of novel MSC-based therapies for OA.
Keywords: multipotent stromal cells, synovial fluid, osteoarthritis, knee joint distraction, subchondral bone,
chondrocytes
INTRODUCTION
Multipotent stromal cells (MSCs), originally termed as
mesenchymal stem cells, are present in different joint
structures including the synovial membrane, synovial fluid (SF),
infrapatellar fat pad, ligaments/tendons, and the subchondral
bone (SB) (Fellows et al., 2016; McGonagle et al., 2017).
Several studies have also described the presence of MSC-like
chondrogenic progenitor cells (CPCs) in the articular cartilage
(Schminke and Miosge, 2014; Jayasuriya et al., 2018). SF MSCs
are a particularly intriguing class of joint-resident MSCs, as
unlike other MSCs, they are not attached to other cells or
surfaces but instead are suspended in a viscous hyaluronan-rich
SF (Jones et al., 2004; Baboolal et al., 2016; Fang et al., 2020). In
healthy individuals, they are believed to be shed from the synovial
intimal layer or superficial cartilage, as a result of mechanical
attrition during joint movement (Jones et al., 2008; Morito et al.,
2008; Lee et al., 2012; Matsukura et al., 2014). Healthy SF MSCs
are highly proliferative and consistently chondrogenic (Jones
et al., 2008; Katagiri et al., 2017). Combined with their ease of
harvesting, despite their limited numbers, they are considered
as an attractive MSC source for repairing focal osteochondral
defects and potentially, joint regeneration in osteoarthritis
(OA), acting via direct differentiation (McGonagle et al., 2017;
Piñeiro-Ramil et al., 2017) as well as paracrine mechanisms
(Garcia et al., 2016).
On the other hand, MSCs present in the SB are accessible
through subchondral plate perforation and are believed to
be responsible for limited cartilage regeneration following
microfracture treatment of focal cartilage lesions (Dwivedi
et al., 2018). In our previous work, we investigated SB
MSCs in advanced knee OA and compared MSCs from
the medial, commonly weight-bearing compartment, with the
lateral side of the joint (Sanjurjo-Rodriguez et al., 2019).
This work used collagenase-assisted release of MSCs from
subchondral trabecular bone surfaces and marrow-filled bone
cavities and demonstrated large MSC numbers in both lateral
and medial femoral condyles. However, in more damaged,
medial condyles, SB MSCs expressed higher levels of ossification-
related genes compared with less-damaged lateral condyles,
indicating their preference for sclerotic bone formation rather
than cartilage restoration and highlighting key contribution on
joint biomechanics in MSC pathophysiology in OA (Sanjurjo-
Rodriguez et al., 2019). These findings are in line with previous
OA animal model studies as well as our previous work on human
hip OA that showed an aberrant osteogenesis of MSCs in OA SB
(Zhen et al., 2013; Ilas et al., 2019, 2020).
Multipotent stromal cells numbers are increased in OA SF
(Jones et al., 2008), in direct correlation with disease severity
(Jones et al., 2008; Sekiya et al., 2012; Harris et al., 2013;
Kim et al., 2015). This has been assumed to represent joint’s
repair attempt, but the source of these additional MSCs and
their cartilage-supportive properties remains unclear. We and
others have previously proposed that additional MSCs are shed
from the synovium and accumulate inside the fluid (Jones
et al., 2008; Katagiri et al., 2017), as a result of their enhanced
proliferation and possibly, reduced attachment to joint structures
(Jones et al., 2008; Harris et al., 2013). Another possibility is
that at least a subset of these OA SF MSCs is liberated from
the damaged articular cartilage, which is the prime “victim” of
tissue destruction in OA (Katagiri et al., 2017). The presence
of “migratory CPCs” in deep OA articular cartilage has been
previously described (Koelling et al., 2009), and these CPCs
may in principle enter the joint space via cracks and fissures in
degenerated cartilage. In the very advanced OA stages, additional
MSCs may also originate from the progressively exposed SB
(Koelling et al., 2009; Iijima et al., 2016).
Knee joint distraction (KJD) is an emerging treatment for OA
(Takahashi et al., 2019; Jansen et al., 2020), which is associated
with impressive structural and clinical outcomes (van der Woude
et al., 2017a; Jansen et al., 2018). It works by simply taking
the load off the joint by surgically pulling the joint apart using
an external fixation frame, which is placed on both sides of
the joint, allowing distraction for a few millimeters for up to
6–8 weeks (van der Woude et al., 2017a). It is considered a
good treatment option for the younger OA subjects in whom
replacement might be premature and more likely to result in early
failure (Schreurs and Hannink, 2017). Patients with established
OA demonstrate improved knee symptoms for 5 to 9 years after
the KJD (van der Woude et al., 2017b; Jansen et al., 2018).
The 6-week period of the off-load leads to apparent cartilage
regeneration, with increase in joint space width (JSW) on X-ray
and increased articular cartilage thickness on magnetic resonance
imaging (MRI) (Wiegant et al., 2013; Jansen et al., 2018, 2019).
First-year minimum JSW on radiographs and cartilage thickness
increase on MRI are predictive of the 9-year results (Jansen et al.,
2018). As such, the initial cartilage repair activity appears to be
important for long-term clinical success. This suggests that, by
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temporarily off-loading the joint, KJD might trigger the intrinsic
cartilaginous repair, which may be facilitated by SF MSCs. Indeed,
in the canine groove model of OA, we showed that MSCs
injected in the SF, following KJD, were capable of integrating
into cartilage injury sites (Baboolal et al., 2016). Furthermore, a
recent study provided evidence for anabolic molecular responses
in SF following KJD, which may act on SF MSCs and represent
potential pathways for cartilage regeneration (Watt et al., 2020).
Based on the fact that SF MSCs and SB MSCs may be
present endogenously at sites of cartilage damage in OA, and that
denuded bone may serve as a potential source of SF MSCs in
advanced OA, we compared their gene expression signatures and
assessed the MSC specificity of differentially expressed transcripts
by comparing them with cultured chondrocytes from the same
joints. We hypothesized that in comparison with SB MSCs,
SF MSCs that are highly chondrogenic in healthy individuals
may be a better MSC population for endogenous manipulation
and cartilage regeneration in OA and that following KJD, their
gene expression signature may change in favor of cartilage
regeneration. The aims of this study were therefore to investigate
gene expression signatures of SF MSCs in advanced knee OA,
in comparison with SB MSCs from the same joints, and to
investigate gene expression changes in SF MSCs following KJD.
MATERIALS AND METHODS
Patients and Samples
This study was performed in compliance with the Declaration
of Helsinki of ethical principles for medical research involving
human subjects. Ethical approval was obtained from the
Yorkshire & The Humber–South Yorkshire Research Ethics
Committee (14/YH/0087). For KJD study, ethical approval
was obtained from the medical ethical review committee
of the University Medical Center Utrecht (#15-160/D;
NL51539.041.15).
Twelve patients who underwent total knee arthroplasty
(median age 72 years, range 61–83; seven women and five men)
were recruited after informed written consent was given, and
both lateral and medial femoral condyle samples were transferred
to the laboratory (Supplementary Figure 1A). From six patients
(median age 80 years, range 64–83; three men and three women),
donor-matched SFs were also collected using a syringe, after
opening the joint cavity for the arthroplasty.
Patients with established symptomatic radiographic knee OA
undergoing KJD gave written informed consent to participate
(n = 9, median 51 age years, range 35–60; two men and
seven women). SF was sampled at baseline (before distraction;
pre), during (3 weeks; during), and at endpoint of distraction
(6 weeks; post).
Tissue Processing for Multipotent
Stromal Cell and Chondrocyte Isolation
Multipotent Stromal Cell Isolation and Expansion
For isolation of MSCs from SF, the fluid was diluted 1:4 in
phosphate-buffered saline (PBS) and centrifuged 500 × g for
10 min, and pelleted cells were seeded in T25 flasks with
StemMACS MSC Expansion Media (Miltenyi Biotec, Germany)
supplemented with 1% penicillin/streptomycin (P/S; Thermo
Fisher Scientific).
For SB MSC isolation, following cartilage removal using a
scalpel, bone from the separate medial and lateral condyles was
mechanically minced into small fragments with a rongeur and
digested with 3,000 units of collagenase/g of tissue (Worthington
Biochem Corp., United States) for 4 h (Supplementary
Figure 1A), as previously described (Sanjurjo-Rodriguez et al.,
2019). The supernatant was filtered through 22-µm cell strainer
(Corning Inc., United States) before centrifugation at 450 × g
for 10 min to pellet the extracted cells. After being counted, the
cells were seeded for culture expansion at the seeding density
of 4.0 × 104 cells/cm2 in flasks containing StemMACS MSC
Expansion Media supplemented with 1% P/S.
Media were changed twice a week, and cells were split when
80% confluence was reached for both types of MSCs. Part of
passage 1 SB and SF MSCs were used for gene expression study,
and passage 3–5 SF cells were used for MSC characterization.
Accrued population doublings (PDs) and PD rates were
calculated as previously described (Churchman et al., 2012).
Chondrocyte Isolation and Expansion
All articular cartilage was harvested from the lateral and medial
condyle surfaces using a scalpel, and chondrocytes were isolated
as described before and kept separate (Sanjurjo-Rodriguez et al.,
2019). We were interested to see whether the nature of cells
(MSCs versus chondrocytes) or their loading environment
(medial versus lateral) had a stronger effect on their gene
expression. Briefly, cartilage was minced using a scalpel and
digested overnight with 3,000 units of collagenase/g of tissue,
and the homogenate was filtered with 22-µm cell strainer. The
supernatant containing cells was centrifuged at 450 × g for
10 min, cell pellet was digested 5 min with 1 × trypsin Thermo
Fisher Scientific, United States), and the cells were seeded into
flasks (Corning Inc.) in Dulbecco’s modified Eagle’s medium
(DMEM; Thermo Fisher Scientific) with 10% fetal bovine serum
(FBS; BioSera, France) and 1% P/S at the seeding density of
1.2 × 104 cells/cm2. Media were changed every 3–4 days, and
subculture was performed when cells reached 80% confluence.
Passage 1-cultured chondrocytes were used for gene expression
analysis as controls for SB and SF MSCs.
Colony-Forming Unit-Fibroblast Assay
Synovial fluid samples were diluted 1:4 in sterile PBS and
thoroughly mixed before centrifuging at 500 × g for 5 min. Cells
were resuspended in 1 ml of warmed StemMACS MSC Expansion
media (Miltenyi Biotec, Germany) supplemented with P/S. Next,
cells were diluted with 9 ml of StemMACS media to a final volume
of 10 ml. Samples were plated in duplicate on colony-forming
unit-fibroblast (CFU-F) dishes (60 mm) by adding 3 ml of the
sample and an additional 2 ml of StemMACS to final volume
of 5 ml per dish. The remaining sample (∼4 ml) was used for
MSC expansion and mRNA analysis. Subsequently, the dishes
were incubated at 37◦C and 5% CO2 in a humidified incubator.
After 2–3 days, the media were removed and replaced with fresh
StemMACS media. Thereafter, half of the media (2.5 ml) were
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refreshed twice weekly. After 14 days, all media were removed,
and cells fixed with 3.7% formalin (buffered with PBS) for 30 min
at room temperature. Formalin was removed, and the dishes were
gently washed with water.
The fixed dishes were stained with methylene blue for
CFU-F counting and were scanned for CFU-F area and
integrated density (ID) analysis, as previously described (Ganguly
et al., 2019; Sanjurjo-Rodriguez et al., 2019). Briefly, scanned
images were converted to 8-bit format, calibrated, and analyzed
using ImageJ software. Colony area and ID were measured
independently in all colonies after thresholding.
Synovial Fluid Multipotent Stromal Cell
Characterization
Characterization of SF MSCs was performed following the
minimal criteria from International Society for Cellular Therapy
(ISCT) (Dominici et al., 2006).
Surface Marker Expression
Synovial fluid MSCs from three randomly selected donors were
characterized by flow cytometry according to the ISCT criteria.
The antibodies used were CD90-FITC (AbD Serotec, Kidlington,
UK), CD73-PE and CD105-PE (both from BD Biosciences,
Wokingham, UK) (MSC positive markers) and CD19-FITC,
CD14-PE, CD34-PE, CD45-V450, and HLA-DR-fluorescein
isothiocyanate (FITC) (hematopoietic lineage markers) (all from
BD Biosciences). A minimum of 10,000 cell events per tube
was acquired using Attune flow cytometer (Applied Biosystems).
Data were analyzed using FlowJo (BD), and the results are
expressed as percentage of positive cells.
Tri-Lineage Differentiation and Motility Assay
Tri-lineage differentiation was performed on the same cultures,
as described before (Sanjurjo-Rodriguez et al., 2019). Briefly, SF
MSCs were seeded in 24-well plates (Corning) for adipogenic
and osteogenic differentiation. Cells were cultured in adipogenic
media containing DMEM supplemented with 12.5% FBS, 12.5%
horse serum, 0.5 mM of isobutylmethylxanthine, 60 µM of
indomethacin, and 0.5 mM of hydrocortisone (all from Sigma)
for 21 days; and adipogenesis was assessed by Oil Red O staining.
Osteogenesis was assessed by Alizarin Red staining after 21-day
culture in osteogenic media containing DMEM supplemented
with 10% FBS, 100 nM of dexamethasone, 0.05 mM of ascorbic
acid, and 100 mM of β-glycerosphosphate (all from Sigma).
Chondrogenic differentiation was performed with
ChondroDiff media (Miltenyi Biotec) in a three-dimensional
(3D) pellet culture for 21 days. Toluidine blue staining was
performed in 5-µm paraffin-sectioned pellets to evaluate
glycosaminoglycan (GAG) content.
In vitro motility of SB and SF MSCs was assessed using
a scratch assay as described before (Sanjurjo-Rodriguez et al.,
2019). Briefly, MSCs were grown to confluence in a 6-well
plate in StemMACS MSC Expansion Media. The media were
removed, and the cell monolayer was scratched with a sterile
200-µl pipette tip. The well was washed with PBS, and new
fresh expansion media were added. Images were taken along the
open scratch at 0 and 24 h, and measurements were calculated
using the ImageJ software. The percentage of uncovered area
(wound open) was normalized to time 0 and compared between
SF MSCs and SB MSCs.
Gene Expression
RNA was isolated from MSCs and chondrocyte cultures,
using the total RNA Purification kit (Norgen Biotek Corp.,
Canada). Gene expression was performed for 95 genes of
interest as described in our previous work (Sanjurjo-Rodriguez
et al., 2019), using standard TaqMan Assays (Thermo Fisher
Scientific) and the 48.48 IFC (Integrated Fluidic Circuit)
with the recommended reagents (Fluidigm Corporation,
United States), following manufacturer’s recommendations.
Hypoxanthine phosphoribosyltransferase 1 (HPRT1) was used
as a housekeeping gene. Reverse transcription was performed,
followed by 14 pre-amplification cycles using a mixture of
96 TaqMan gene expression assays (Supplementary Table 1).
The Dynamic 48.48 IFC sample compartment was loaded with
the diluted pre-amplified cDNAs mixed with sample loading
buffer (Fluidigm Corporation) and TaqMan Universal PCR
Master mix (Applied Biosystems, United States). The IFC assay
compartment was loaded with the 96 TaqMan assays mixed with
assay loading buffer (Fluidigm Corporation). The IFC was then
run on the Biomark Real Time PCR System using a GE 48 × 48
Standard v1 PCR thermal protocol, and data were analyzed using
BioMark Gene Expression Data software and normalized to
the housekeeping gene. Genes differentially expressed between
chondrocytes, SB, and SF MSCs were further scrutinized for
hierarchical clustering analysis using Cluster 3.0 software
and Java TreeView (Churchman et al., 2012), including only
samples that expressed ≥60% of all genes and genes expressed in
≥80% of the samples.
Statistical Analysis
Results were analyzed using Kruskal–Wallis and Dunn’s multiple
comparison tests for unpaired data and Wilcoxon signed
rank tests for donor-matched data. The statistical analysis was
performed using Prism software (version 7.0 a; GraphPad). The
difference between the groups was considered as statistically
significant only if the p value <0.05.
RESULTS
Osteoarthritis Synovial Fluid Multipotent
Stromal Cell Characterization
Synovial fluid MSC cultures were established according to
standard methods (Jones et al., 2004). SB MSC cultures were
derived and characterized from both medial and lateral femoral
condyles, as previously described (Sanjurjo-Rodriguez et al.,
2019). There was no significant difference in the growth rates
or surface phenotypes of SF MSC cultures and both types of
SB MSCs (Figures 1A,B). Consistent with their MSC nature, SF
cultures were tri-potential (Figure 1C). In motility assays, SF
MSCs moved slightly faster than medial SB MSCs but were slower
that lateral SB MSCs, and the differences failed to reach statistical
significance (Figure 1D).
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FIGURE 1 | Phenotypical and functional analyses of multipotent stromal cells (MSCs). (A) Comparison of growth rates of medial and lateral subchondral bone (SB)
MSCs (SB MSC M and SB MSC L, respectively) and synovial fluid (SF) MSCs measured as population doubling (PD) times (in days). Dots represent individual
donors; error bars represent interquartile range (IQR). (B) Phenotypic profile of culture-expanded SF and medial and lateral SB MSCs indicating no differences in the
expression of standard MSC markers. Horizontal bars show means and error bars represent standard error (n = 3 donors). (C) Example images of SF MSC
adipogenesis assay (Adipog) stained with Oil Red O after 14 days of adipogenic induction (top panel, original magnification ×100), osteogenesis (Osteog) showing
positive alizarin red staining on day 14 post osteogenic induction (medium panel, original magnification ×100), and toluidine blue staining for glycosaminoglycan
(GAG) deposition (purple) of chondrogenic (Chondrog) pellet cultures on day 21 post induction (bottom panel, original magnification ×40). (D) Analysis of SF MSC
motility showing no significant differences between MSCs. Top panel: graph representing the median percentage of wound uncovered by migrating cells after 24 h
(relative to the corresponding 0-h area); data represent individual measurements from nine SB MSC donors and three SF MSC donors; error bars represent IQR.
Bottom panels: example images showing uncovered area measured at time 0 and at 24 h (t24).
Gene Expression Differences Between
Synovial Fluid Multipotent Stromal Cells,
Subchondral Bone Multipotent Stromal
Cells, and Chondrocytes
Global gene expression differences between all culture types
were first investigated using cluster analysis and revealed a
clear clustering of SF MSCs and SB MSCs away from cultured
chondrocytes from the same joints (Figure 2A). Also, within
MSCs, a clear sub-cluster of SF MSCs was evident. Statistical
analysis was next performed to identify differentially expressed
genes between all MSCs and all chondrocytes (Figures 2B,C).
The most differentially expressed genes highly expressed in
chondrocytes were as follows: cartilage oligomeric matrix protein
(COMP), lipocalin 2 (LCN2), nitric oxide synthase 2 (NOS2),
interleukin 10 (IL10), C–C motif chemokine ligand 20 (CCL20),
also known as macrophage inflammatory protein-3, and C–C
motif chemokine receptor 7 (CCR7). All of these genes were
expressed in cultured chondrocytes and low or below detection
in both SF and SB MSCs (Figure 2B).
In contrast, four genes were significantly higher expressed in
both SB and SF MSCs, compared with cultured chondrocytes
(Figure 2C). These genes were C–X–C motif chemokine 12
(CXCL12, 58-fold higher in SB MSCs and 234-fold higher in
SF MSCs), tissue inhibitor of metalloproteinase-3 (TIMP3; 7.7-
fold higher in SB MSCs and 36.7-fold higher in SF MSCs),
sphingosine kinase 1 (SPHK1; 6.5-fold higher in SB MSCs and
11.9-fold higher in SF MSCs), and transforming growth factor
beta 1 (TGFB1; 6.9-fold higher in SB MSCs and 9.6-fold higher
in SF MSCs). None of these four genes was significantly different
between SB and SF MSCs. These data indicated that as expected,
SF MSC gene expression signature was more similar to SB MSCs
than cultured chondrocytes.
Gene Expression Comparison Between
Synovial Fluid Multipotent Stromal Cells
and Medial and Lateral Subchondral
Bone Multipotent Stromal Cells
Synovial fluid MSC gene expression signature was next compared
with medial and lateral SB MSCs. When gene expression profiles
of SF MSCs were compared with those of medial SB MSCs,
82% of the measured genes showed similar levels of expression
(Supplementary Table 1), 7% genes showed significantly >2-
fold higher expression in medial SB MSCs, and 11% of genes
were significantly >2-fold higher expressed in SF MSCs (Table 1).
Similarly, when gene expression profiles of SF MSCs were
compared with lateral SB MSCs, 69% of genes showed similar
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FIGURE 2 | Gene expression analysis of culture-expanded medial and lateral subchondral bone (SB) multipotent stromal cells (MSCs) (SB MSC M and SB MSC L,
respectively), synovial fluid (SF) MSCs, and medial and lateral chondrocytes (CH M and CH L, respectively). (A) Cluster analysis between CH, SB MSCs, and SF
MSCs illustrating clear clustering of MSCs away from chondrocytes. Data were normalized to the housekeeping gene HPRT and log2 transformed. Data filtering was
performed according to standard methods previously described (Churchman et al., 2012). Scores were assigned as: black = 1, red > 1, green < 1; gray = missing
data (below detection). (B) Differentially expressed genes with a significant higher expression in chondrocytes than in MSCs. L.D. indicates transcripts which were
rarely expressed (in < 50% samples), and B.D. indicates transcripts below detection. (C) Differentially expressed genes between chondrocytes and MSCs, which
were statistically significantly higher expressed in MSCs than in chondrocytes. *p < 0.05; **p < 0.01; ***p < 0.0001. Horizontal bars show medians and error bars
represent interquartile range (IQR). REU, relative expression units [relative to housekeeping hypoxanthine phosphoribosyltransferase (HPRT)].
levels of expression (Supplementary Table 1), 5% genes showed
significantly >2-fold higher expression in lateral SB MSCs, and
26% of genes were significantly >2-fold higher expressed in
SF MSCs (Table 1). Interestingly, genes previously described as
highly specific for synovial-origin MSCs, such as SFRP4 (Sekiya
et al., 2012; Baboolal et al., 2014) and growth differentiation factor
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TABLE 1 | Gene expression differences between SF and either lateral or medial SB MSCs.
Lower expression in SF than SB MSCs
Gene symbol Gene name Medial SB MSCs > SF Lateral SB MSCs > SF
Fold difference p-value Fold difference p-value
SP7 Sp7 transcription factor SF B.D. N/A SF B.D. N/A
IBSP Integrin binding sialoprotein SF L.D. N/A SF L.D. N/A
LEPR Leptin receptor SF L.D. N/A SF L.D. N/A
PTH1R Parathyroid hormone 1 receptor SF L.D. N/A SF L.D. N/A
RUNX2 Runt-related transcription factor 2 3.94 <0.05 6.38 <0.01
IGF2 Insulin-like growth factor 2 3.13 <0.05 4.83 <0.01
PTGS2 Prostaglandin-endoperoxide synthase 2 3.79 <0.05 4.03 NS
Higher expression in SF than SB MSCs
Gene symbol Gene name SF > medial SB MSCs SF > lateral SB MSCs
Fold difference p-value Fold difference p-value
CCL5 C–C motif chemokine ligand 5 Med L.D. N/A Lat L.D. N/A
PTHLH Parathyroid hormone-like hormone 6.35 <0.05 Lat L.D. N/A
MMP9 Matrix metalloproteinase 9 4.28 NS Lat L.D. N/A
STMN2 Stathmin 2 11.57 NS Lat L.D. N/A
ACAN Aggrecan 1.93 <0.05 2.21 NS
THBS4 Thrombospondin 4 57.12 <0.05 78.52 <0.01
MMP1 Matrix metalloproteinase 1 36.95 <0.05 52.90 <0.01
CCR1 C–C motif chemokine receptor 1 8.08 <0.05 10.52 <0.05
ADAMTS5 A disintegrin and metalloproteinase with thrombospondin motifs 5 10.32 <0.01 8.47 <0.01
VEGFC Vascular endothelial growth factor C 5.38 <0.01 5.46 <0.01
TIMP3 Tissue inhibitor of metalloproteinase-3 4.60 <0.01 5.20 <0.01
POSTN Periostin 2.06 <0.05 2.59 <0.05
TGFBR3 Transforming growth factor beta receptor 3 2.59 <0.05 3.43 <0.01
TGFBR2 Transforming growth factor beta receptor 2 2.55 NS 4.87 <0.001
DDR2 Discoidin domain receptor tyrosine Kinase 2 2.31 NS 2.33 <0.01
IGFBP3 Insulin-like growth factor binding protein 3 2.37 NS 8.08 <0.001
MMP3 Matrix metalloproteinase 3 12.58 NS 24.15 <0.05
CCL2 C–C motif chemokine ligand 2 2.59 NS 3.92 <0.01
NGF Nerve growth factor 1.73 NS 3.18 <0.01
GREM1 Gremlin 1, DAN family BMP antagonist 0.97 NS 3.14 <0.05
SERPINE1 Serpin family E member 1 2.16 NS 3.12 <0.01
CTGF Connective tissue growth factor 1.63 NS 2.49 <0.01
PPARδ Peroxisome proliferator activated receptor delta 1.87 NS 2.26 <0.05
MMP2 Matrix metalloproteinase 2 1.84 NS 2.23 <0.05
Kruskal–Wallis test with Dunn’s correction for multiple comparisons. L.D., low detection; B.D., below detection; N/A, not applicable; NS, not significant.
5 (GDF5) (Kania et al., 2020), were not expressed at the higher
levels in OA SF MSCs (Table 1).
To summarize, compared with both medial and lateral
SB MSCs, SF MSCs expressed lower levels of osteogenesis-
related genes, consistent with our original hypothesis that
SF MSCs were less osteogenically committed (McGonagle
et al., 2017) (Figure 3A). The expression of bone-anabolic
insulin growth factor 2 (IGF2) (Kang et al., 2012), and the
osteogenic transcription factor (TF) Runx2, was significantly
lower in SF MSCs compared with SB MSCs using both
unpaired and paired tests, and the expression IBSP (encoding
bone sialoprotein) displayed low detection frequency in SF
MSCs, precluding its full statistical analysis using paired
tests but indicating its very low expression levels in SF
MSCs (Figure 3A). Expression of parathyroid hormone 1
receptor (PTH1R) was also below detection in more than
50% of SF MSCs. PTH1R regulates cartilage hypertrophy and
bone turnover (Santa Maria et al., 2016) and is indirectly
implicated in promoting osteoclastogenesis, along with
IGF2 and prostaglandin-endoperoxide synthase 2 (PTGS2)
(Benisch et al., 2012).
Compared with SB MSCs, SF MSCs expressed similar levels
of classical chondrogenesis-related TF SOX9 (Supplementary
Table 2) but higher levels of aggrecan (ACAN) (significant in
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FIGURE 3 | Gene expression analysis of culture-expanded medial and lateral subchondral bone (SB) multipotent stromal cells (MSCs) (SB MSC M and SB MSC L,
respectively) and synovial fluid (SF) MSCs pointing toward MMP and other pathway activation in SF MSCs. (A) Genes expressed significantly higher in SB MSCs
than SF MSCs. (B) Differentially expressed genes with a significant higher expression in SF MSCs than in SB MSCs. *p < 0.05; **p < 0.01; ***p < 0.0001.
Horizontal bars show medians, and error bars represent interquartile range (IQR). REU, relative expression units [relative to housekeeping hypoxanthine
phosphoribosyltransferase (HPRT)]. L.D. indicates transcripts which were rarely expressed (detected in <50% samples).
medial SB MSCs). Unexpectedly, SF MSCs expressed significantly
higher levels of genes involved in cartilage catabolism and
extracellular matrix turnover (Figure 3B). The expression of
matrix metalloproteinases 9 (MMP9) and 1 (MMP1), and tissue
inhibitor of metalloproteinase-3 (TIMP3) and transforming
growth factor receptor 3 (TGFBR3) were significantly higher
in SF MSCs. Interestingly, high-level expression of extracellular
matrix-degrading enzymes and their inhibitors has been
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previously described as a distinctive feature of OA migratory
CPCs (Koelling et al., 2009). Other interesting genes expressed
higher in SF MSCs were thrombospondin 4 (THBS4), serpin
family E member 1 (SERPINE1), and vascular endothelial
growth factor C (VEGFC), among others (Figure 3B), all
previously described as involved in cartilage formation, cartilage
metabolism, or cartilage changes in OA (Hissnauer et al., 2010;
Seol et al., 2012; Ludin et al., 2013).
Changes in Synovial Fluid Multipotent
Stromal Cell Numbers and Colony
Characteristics Following Knee Joint
Distraction
A different cohort of nine OA patients was next analyzed to
detect any changes in SF MSCs following KJD. CFU-F assays were
first performed to quantify MSCs in donor-matched SF samples
before, during, and after KJD (at weeks 0, 3, and 6, respectively).
Out of nine patients studied for CFU-F, three had all three time-
points available (Figure 4A). No particular trend was observed
in relation to colony numbers following KJD (Figure 4B). The
colony areas and IDs were next quantified to assess any potential
changes in MSC proliferation. Week 0 colonies were more
homogenously distributed with smaller colonies compared with
week 3 and 6 colonies (Figure 4C). Colony IDs, which are an
integrated measure of colony area and density, were significantly
higher at weeks 3 and 6 compared with week 0 (p < 0.001)
(Figure 4D). Correspondingly, the growth rates at early passage
week 3 and week 6 MSCs were higher compared with week 0
MSCs (means of 1.65, 1.67, and 1.81 days/PD, respectively), but
the differences failed to reach statistical significance. Altogether,
these data indicated a slight increase in SF MSC proliferative
capacity following KJD.
Changes in Synovial Fluid Multipotent
Stromal Cell Gene Expression Following
Knee Joint Distraction
The baseline (week 0) gene expression of SF MSCs from the
KJD cohort was next compared with that of SF MSCs from
OA arthroplasty cohort. No significant differences in the cell
numbers at passage 0 normalized to a milliliter of SF were
found between the two cohorts, indicating similarities in MSC
growth potentials (Supplementary Figure 2A). Both cohorts had
FIGURE 4 | Synovial fluid (SF) multipotent stromal cell (MSC) colony numbers and characteristics following knee joint distraction (KJD). (A) Colonies formed by
MSCs at weeks 0, 3, and 6 from three patients. (B) Quantification of colony numbers (total numbers); each color represents individual patient. (C) Colony area
frequency distribution showing a shift toward larger colonies following KJD. (D) Quantification of colonies integrated density using Image J (1,432, 833, and 744 total
colonies at weeks 0, 3, and 6, respectively). ***p < 0.0001; horizontal lines represent medians.
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similarly lower bone-related IGF2, IBSP, and RUNX2 transcript
expression compared with SB MSCs from the arthroplasty cohort
(Supplementary Figure 2B). Similarities in the expression of
other transcripts were less obvious, and the baseline (week
0) data from the KJD cohort were next compared with
week 3 and 6 data to elucidate any changes in SF MSCs
toward a more chondrogenic, cartilage-anabolic, or anti-catabolic
phenotype following KJD.
We first looked at transcripts overexpressed in SF MSCs
compared with SB MSCs, and no significant changes or
prominent trends were observed for IGFBP3, PPARδ, CCL5,
TIMP3, and SERPINE1 (data not shown). However, a sustained
nearly 10-fold reduction in the transcript levels for CCL2,
encoding monocyte chemotactic protein 1 (MCP1), was observed
in SF MSCs from the distracted joints (weeks 3 and 6)
compared with week 0 (Figure 5A). A similar trend was
observed for CCL20, encoding macrophage inflammatory
protein-3 (MIP3α), but the differences failed to reach statistical
significance. TNFRSF11B expression (encoding bone-anabolic
osteoprotegerin) was also reduced at weeks 3 (3.8-fold) and
6 (2.5-fold) compared with week 0 (p < 0.05) (Figure 5B),
and the expression of IBSP (encoding bone sialoprotein) was
also consistently reduced albeit non-significantly. The expression
of FABP4 (fatty acidic protein 4) or SOX9 (the master
regulator of MSC chondrogenesis) was also reduced (Figure 5C);
however, the expression of ACAN (core protein for a large
cartilage proteoglycan essential for cartilage extracellular matrix
maintenance) (Roughley and Mort, 2014) was, in contrast,
significantly increased (Figure 5D).
Many transcripts displayed a trend for a decline following KJD
but failed to reach significance, including MMP1, parathyroid
hormone-like hormone (PTHLH), connective tissue growth
factor (CTGF), THBS4, a disintegrin and metalloproteinase
with thrombospondin motifs 5 (ADAMTS5), MMP9, and IL1b
(interleukin 1 beta). Altogether, these data indicated a trend for
a sustained reduction in cartilage-catabolic transcripts following
KJD, with some evidence for increased ACAN expression (4.2-
fold, p < 0.01 after 3 weeks) and (2.9-fold, p < 0.05 after 6 weeks)
of KJD compared with its baseline levels (Figure 5D).
We next tested the hypothesis that KJD may rapidly activate
joint repair pathways that would regress by 6 weeks when
MSC joint repair mechanisms should be well under way
(Baboolal et al., 2016). Therefore, we separately considered
a group of transcripts that showed a significant change
in their expression levels at week 3 followed by “return
to baseline” at week 6 (Figure 6). Remarkably, this group
included GDF5 (4.8-fold increase at week 3, p < 0.01),
associated with chondrogenic specification in joint interzone
and synovium (Kouroupis et al., 2019) and cartilage-resident
progenitors (Kania et al., 2020), and gremlin 1 (GREM1)
(3.9-fold at week 3, p < 0.001) described as characteristic
for osteochondroreticular stem cells within the metaphysis of
long bones (Worthley et al., 2015) and enriched in healthy
articular cartilage where it regulates hypertrophy (Leijten et al.,
2013) (Figure 6A). A similar pattern of changes was seen for
TGFBR2 and TGFBR3 (Figure 6B) and IGFR (Figure 6C),
the receptors for cartilage-anabolic growth factors and involved
FIGURE 5 | Gene expression changes in synovial fluid (SF) multipotent
stromal cells (MSCs) following knee joint distraction (KJD): sustained changes.
(A) Reduction in chemokine transcripts CCL2 and CCL20. (B) Reduction in
bone-anabolic transcripts TNFRSF11B and IBSP. (C) Reduction in FABP4 and
Sox9 transcripts. (D) Increase in ACAN transcripts. *p < 0.05; **p < 0.01;
***p < 0.0001. Horizontal bars show medians, and error bars represent
interquartile range (IQR). REU, relative expression units [relative to
housekeeping hypoxanthine phosphoribosyltransferase (HPRT)].
in pathogenesis of OA (Goldring, 2000). VEGFC, a well-
known pro-angiogenic factor, showed a small decrease (1.6-fold,
p < 0.05) at week 3 and returned to baseline after 6 weeks
(Figure 6C). The VEGF family have been associated with OA
progression in all tissues in the joint (Hamilton et al., 2016) and
found strongly expressed in hyperplasic osteoarthritic synovium
(Paavonen et al., 2002).
Overall, this pattern of gene expression indicated an early
upregulation of genes associated with chondrogenic lineage
specification and responsiveness to cartilage-anabolic growth
factors, which may explain a more sustained increase in ACAN
expression. At the end of KJD, there was also reduction
in a pro-inflammatory CCL2/MCP-1 gene expression in SF
MSCs as well as downregulation of typical bone- and fat-
lineage genes.
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FIGURE 6 | Gene expression changes in synovial fluid (SF) multipotent stromal cells (MSCs) following knee joint distraction (KJD): temporary changes. (A) Increase
at week 3 and reduction at week 6 in progenitor-marker transcripts GDF5 and GREM1. (B) Similar trend in anabolic growth factor transcripts TGFBR2 and TGFBR3.
(C) Increase in insulin growth factor receptor (IGFR) and reduction in vascular endothelial growth factor C (VEGFC) transcripts at week 3. *p < 0.05; **p < 0.01;
***p < 0.0001. Horizontal bars show medians, and error bars represent interquartile range (IQR). REU, relative expression units [relative to housekeeping
hypoxanthine phosphoribosyltransferase (HPRT)].
DISCUSSION
Novel therapeutic interventions based on the modulation of
local biomechanical or biological environments within the OA-
affected joint have recently emerged as potential joint-sparing
alternatives to joint replacement surgery (Sánchez et al., 2012;
Jansen et al., 2018; Goh et al., 2019; Jansen et al., 2019;
Takahashi et al., 2019). Harnessing endogenous joint repair
mechanisms following biomechanical correction of OA joints
following KJD appears to hold particular promise (Mastbergen
et al., 2013; McGonagle et al., 2017). While their mechanisms
of action remain to be fully elucidated, endogenous SB and
SF MSCs have been suggested as potential contributors to
structural improvements and cartilage regeneration following
these treatments (Chen et al., 2015; Baboolal et al., 2016; Sánchez
et al., 2016). In this study, we investigated gene expression
profiles of SF and SB MSCs in advanced knee OA and explored
whether KJD, a successful treatment for advanced OA, leads to
any favorable cartilage-anabolic changes in SF MSCs.
At the beginning, we compared gene expression profiles of SF
MSCs and SB MSCs with articular chondrocytes enzymatically
extracted from the same joints. Our results showed clear
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clustering of chondrocytes away from both types of MSCs
indicating toward less-differentiated nature of both types of
MSCs. Recent studies have indicated the existence, within
the OA cartilage, of highly proliferative and migrating CPCs
(Koelling et al., 2009; Fellows et al., 2017; Carluccio et al., 2020),
which could in theory, be shed into the SF and contribute
to increased levels of matrix-turnover molecules in SF MSCs.
Chondrocyte cultures, which were derived from the full-depth
OA cartilage in the present study, could also contain the progeny
of these migrating CPCs. Our data on chondrocyte cultures
showed their higher-level expression of typical cartilage-specific
molecules, compared with MSCs, as well as some evidence of
chondrocyte inflammation, based on increased expression of pro-
inflammatory molecules lipocalin-2 (LCN2) (Choi and Chun,
2017), NOS2 (Ahmad et al., 2020), CCL20 (Alaaeddine et al.,
2015), and C–C motif chemokine receptor 7 (CCR7). These data
indicated clear differences in gene expression profiles between
cultured full-depth cartilage-resident cells and MSCs from the
same late-OA joints and pointed toward cartilage degradation
and inflammation as potential contributing factors to MSC gene
expression signatures in late-stage OA joints.
In agreement with Djouad et al. (2005) for healthy bone
marrow MSCs and SF MSCs, SB MSCs and SF MSCs formed
separate sub-clusters within the MSC cluster in our study. This
could indicate different tissue origins of these MSCs (Sekiya et al.,
2012; McGonagle et al., 2017), but this could also be a reflection
of different biomechanical environments that these MSCs reside
in. We have previously shown that SB MSCs from medial (more
loaded) femoral condyles had a gene expression profile enriched
for bone-anabolic genes compared with MSCs from lateral (less
loaded) condyles, implicating joint biomechanics as a potential
main driver of SB MSC commitment to osteogenesis and sclerotic
plate formation in late-OA joints (Sanjurjo-Rodriguez et al.,
2019). In the present study, SF MSCs under-expressed many
of these osteogenic and hypertrophy-related genes compared
with SB MSCs (IGF2, RUNX2, IBSP, and PTH1R) supporting SF
MSC role in endogenous cartilage repair in vivo in experimental
OA (Wiegant et al., 2015) and arguing for better suitability
of SF MSCs for cartilage regeneration in OA in humans
(Baboolal et al., 2016).
The lack of a clear pro-chondrogenic or cartilage anabolic
phenotype of OA SF MSCs could at least in part be related
to pro-inflammatory mediators present in late-OA SF (Monibi
et al., 2016). Indeed, OA SF MSCs expressed higher levels of
many genes related to cartilage catabolism and extracellular
matrix turnover (including ADAMTS5, MMP1, and TIMP3)
compared with SB MSCs. This is similar to CPCs, which
express high levels of these molecules, possibly to facilitate their
tissue egress and remodeling of damaged extracellular matrix
(Koelling et al., 2009). Such a unique gene expression profile
may also reflect a strong effect of cartilage breakdown and joint
inflammation on SF MSCs (Leijs et al., 2012; Neybecker et al.,
2018). Regardless of the cause, this gene expression profile might
be of relevance to remodeling the damaged cartilage matrix and
enabling endogenous repair by SF MSCs.
Higher numbers, but reduced functionalities of MSCs in OA
SF compared with healthy donors, have been reported in many
previous studies (Jones et al., 2008; Sekiya et al., 2012; Kim
et al., 2015), but the precise mechanisms behind this unexpected
increase remain unknown. The molecular and metabolic milieu
of OA SF may encourage resident MSC self-renewal (Jones
et al., 2008; Harris et al., 2013), but it may also induce the
egress of CPCs and SB MSCs from their natural niches (Sánchez
et al., 2016; De Luca et al., 2019) or reduce their homing
and attachment to damaged cartilage and other joint tissues
(Endres et al., 2007; Baboolal et al., 2016; De Luca et al., 2019).
Another promising joint-preserving regenerative treatment for
severe OA, a combination of intra-articular and intra-osseous
infiltrations of autologous platelet-rich plasma (PRP), has been
shown to reduce SF MSC numbers measured by flow cytometry
(Muiños-López et al., 2016; Sánchez et al., 2016), presumably
by attraction of MSCs to the exposed osseous surface. In our
cohort of KJD patients, SF MSC numbers measured by CFU-F
assay did not increase or fall following the treatment, although
higher colony densities during treatment pointed toward their
slightly increased proliferative capacity that may in part be driven
by KJD-associated changes in SF FGF2 concentration (Coutu
et al., 2011; Watt et al., 2020). We acknowledge that aspirated
SF MSC numbers could not be volumetrically counted, as the
volumes of fluid taken from the patients could not be precisely
controlled and depended on patient’s clinical status; therefore,
the data were presented as total aspirated MSCs. Nevertheless, SF
MSC responses to KJD appeared to be different to those reported
following PRP infiltrations.
Our analysis of SF MSC transcriptome half-way through
(week 3) and in the end of KJD (week 6) provided interesting
insights into the dynamics of SF MSC responses in relation
to previously reported SF cytokine changes (Watt et al., 2020).
In a separate cohort of 20 KJD patients, mild but sustained
increases in SF levels of FGF2 and TGFb1 have been recently
documented, which were particularly prominent in patients who
responded better to their treatment (Watt et al., 2020). Our
data showed an increase in TGFβ receptor 2 and 3 expression
in SF MSCs early in KJD, which may represent an enrichment
in TGFβ-responsive MSCs during early stages of treatment.
Interestingly, this coincided with higher-level GREM1 and GDF5
transcripts in week 3 MSCs, the molecules associated with
chondrogenesis and healthy cartilage homeostasis (Leijten et al.,
2013; Worthley et al., 2015; Kouroupis et al., 2019; Kania et al.,
2020). A sustained increase in ACAN expression in SF MSCs
following KJD suggests some degree of their chondrogenic
commitment and may be explained by the activity of these
GREM1- and GDF5-expressing cells.
It is difficult to directly compare the gene expression of
SF MSCs following KJD with our results obtained for their
comparison with SB MSCs, as different patient cohorts were
used. Some key similarities in SF MSCs from both cohorts were
however found, particularly in relation to their reduced levels of
osteogenic transcripts IGF2, IBSP, and RUNX2, compared with
SB MSCs, as well as similar growth potentials. However, it was
noted that several genes higher expressed in the OA SF MSCs
and assumed to be upregulated in response to pro-inflammatory
SF mediators (ADAMTS5, IL1b, MMP9, or MMP1) in our
OA arthroscopy cohort did not show a significant change
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following KJD, but they tended to decrease. Interestingly, SF
MSC expression of pro-inflammatory chemokines (CCL2/MCP1
and CCL20/MIP1α) was reduced. MCP1 is associated with
synovial inflammation (Wang et al., 2013) and implicated in
joint pain (Miotla Zarebska et al., 2017), as well as an inhibition
of SF MSC chondrogenesis (Harris et al., 2013). In contrast
to an animal model studies where a significant effect of KJD
on joint inflammation was found (Chen et al., 2015; Wiegant
et al., 2015), early results on the effects of KJD on SF pro-
inflammatory mediators in OA patients remain puzzling. For
example, pro-inflammatory IL-6 and MCP1 SF levels were
found increased following KJD in Watt et al. (2020) study,
although IL-6 was negatively correlated with pro-chondrogenic
TGFb1, as would be expected (Wiegertjes et al., 2019). Larger
studies investigating more SF analytes and SF MSC transcripts
using the same cohort of patients (validation cohort), ideally
at more time-points, during the course of distraction and
comparing responders and non-responders, would be needed
to shed more light on the effects of joint off-loading on
SF cellular and molecular responses. Changes in SF MSC
secretome and their immunomodulation, chondrogenic and
chondroprotective potencies using appropriate assays (Cassano
et al., 2018; Amemiya et al., 2020; Watanabe et al., 2020) would
be needed to confirm the functional significance of the observed
transcript changes. In addition to MSCs, the investigations of SF
immune cells, and particularly macrophage subsets in terms of
their pro- and anti-inflammatory polarization states (Fahy et al.,
2014; Daghestani et al., 2015), would be necessary.
This study is limited by small numbers of samples tested
and by the analysis of SB and SF MSC expression in culture-
expanded MSCs, which is known to influence gene expression
(Churchman et al., 2012; Sanjurjo-Rodriguez et al., 2019). We
have previously demonstrated the feasibility of analyzing gene
expression in uncultured SB MSCs from knee OA patients where
differentially expressed genes between lateral and medial femoral
condyles were discovered using cultured MSCs and subsequently
confirmed using CD271-selected uncultured MSCs (Sanjurjo-
Rodriguez et al., 2019). However, the isolation of uncultured
SF MSCs, which are significantly rarer (Jones et al., 2004, 2008;
Morito et al., 2008; Altaie et al., 2018), remains a challenge.
New methodologies involving single-cell quantitative PCR or
RNA sequencing, as utilized for other types of rare stem cells
(Ayyaz et al., 2019; Tricoire et al., 2019; Zhou et al., 2019),
provide a future way forward. Our chondrocyte cultures were
derived from full-depth OA cartilage and grown in culture media
different from MSC-expansion media; this could have partially
contributed to differences in their gene expression compared with
MSCs. Similarly, single-cell RNA sequencing (Ji et al., 2019) or
mass cytometry (Grandi et al., 2020) on cartilage-resident cells
including uncultured CPCs and comparing their profiles with
single MSCs would provide future valuable insights into different
progenitor and stem cell types present in OA-affected human
joints. If cultured, the same early passage cells should be used for
transcript analysis and functional assays.
Apart from SF MSCs, joint off-loading following KJD is likely
to have an impact on SB MSCs, but bone biopsy was considered
too invasive and therefore deemed unethical. The assessment
of SB microstructural changes using CT scans (Intema et al.,
2011) and correlating them with SB MSC changes and cartilage
regeneration (Hyodo et al., 2019) would be valuable for future
evaluation of the roles of SB MSCs in osteochondral structural
improvements and cartilage metabolism (Westacott et al., 1997)
following KJD. Finally, primary biomechanical effects of joint
off-loading are also possible, for example, SF viscosity changes,
hyaluronan content, or cartilage swelling, which are potential
drivers for SF attachment to cartilage occurred within the
first week following off-loading (Baboolal et al., 2016) and
were therefore missed in the present study protocol. Future
studies should also include investigations of synovial MSC
subpopulations and comparing them, through high-throughput
single cell-based analysis, to SF MSCs. Up to now, there
exist multiple studies presenting different phenotypes and
topographies of MSCs in human synovium (Sivasubramaniyan
et al., 2012; O’Brien et al., 2017; Mizuno et al., 2018; Affan
et al., 2019) or rodent synovium (Roelofs et al., 2017); and their
relationships with synovial fibroblasts (Croft et al., 2019), which
may be pro-inflammatory, remain unclear. In the future, it would
be interesting to establish which subset of synovial MSCs may be
preferentially shed into the fluid, using recently developed in vitro
methodologies (Kohno et al., 2018). Endogenous manipulations
of the osteoarthritic synovium toward inflammation inhibition
and increased MSC shedding into the fluid could be the next step
toward KJD efficacy augmentation.
Our findings have broad implications for the development
of novel joint-sparing regenerative strategies as they highlight
the complexity of different joint-resident MSC niches, MSC
responses to the disease itself, and dynamic changes favoring
tissue repair following biomechanical correction by joint off-
loading. Many clinical investigations employ MSC intra-articular
injections as a sole therapy based on their tissue repair and
immunomodulatory activities in vitro (Chahal et al., 2019; Matas
et al., 2019), but long-term clinical benefits are not always
guaranteed (Shariatzadeh et al., 2019). Our data highlight the
importance of considering complex cellular and biomechanical
environments into which these cells are delivered for the
development of more effective joint-sparing treatments for OA.
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Supplementary Figure 1 | Tissue processing (A) and the immunohistochemical
staining of an example osteochondral specimen (B) showing an absence of intact
cartilage superficial layer and the presence of CD271 + MSCs in marrow cavities
(dotted arrows) and in bone-lining locations (black arrows). Dotted line represents
an approximate position of slicing-off the cartilage using a scalpel. The method for
processing and immunohistochemical staining of OA knee osteochondral
specimens can be found in “Materials and Methods” and “Supplementary
Material”.
Supplementary Figure 2 | Comparison between SF MSCs from OA arthroplasty
(OA/A) cohort and SF MSCs from KJD cohort at baseline (week 0). Similar growth
potentials were observed (A) (lines represent medians, each symbol represents an
individual donor). Gene expression heatmap of SF MSCs from both cohorts: OA/A
(n = 6), KJD (n = 8), and SB MSCs from OA/A cohort (n = 11) used as comparator
(B). Heatmap is generated using Graphpad Prism version 8.4.3. Log2
transformation and data filtering (filter = 67% present) were performed on the data
and color coding represents medians. Osteogenic genes differentially expressed
between SB MSCs and both groups of SF MSCs are shown in yellow brackets.
Supplementary Table 1 | Taqman probes used to assess the gene expression.
Supplementary Table 2 | Genes not differentially expressed between SF and
SB MSCs.
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